MacroGenics | MGNX - Operating Profit

Stock Price
1.70
Daily Change
-0.03 -1.73%
Monthly
0%
Yearly
-38.63%
Q1 Forecast
1.77

MacroGenics reported $18.64M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
AbbVie USD 5.81B 1.23B Dec/2025
Amgen USD 3.96B 464M Dec/2025
AstraZeneca USD -1.5B 5.01B Sep/2025
Biogen USD 659.6M 192.2M Sep/2025
Bristol-Myers Squibb USD 3.64B 135M Sep/2025
Daiichi Sankyo JPY 89.54B 42.01B Dec/2025
Eli Lilly USD 8.99B 599.9M Dec/2025
Genmab DKK 360M 172M Jun/2025
Geron USD -13.89M 1.43M Sep/2025
Gilead Sciences USD 3.51B 810M Sep/2025
J&J USD 5.59B 1.81B Dec/2025
MacroGenics USD 18.64M 55.4M Sep/2025
Merck USD 6.24B 318M Dec/2025
Pfizer USD 4.65B 3.99B Dec/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Xencor USD -47.52M 14.35M Sep/2025